Healthcare Press Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.

Press releases published on September 28, 2026

11 hours ago

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Indeterminate GlobeNewswire

11 hours ago

Lifecore Biomedical to be Acquired by Webster Equity Partners

Indeterminate GlobeNewswire

11 hours ago

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

Indeterminate GlobeNewswire

11 hours ago

Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers

Indeterminate GlobeNewswire

11 hours ago

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Indeterminate GlobeNewswire

11 hours ago

Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

Indeterminate GlobeNewswire

11 hours ago

DLH Awarded New NIH Cybersecurity Operations Task Order Valued at Up to $19.1 Million

Indeterminate GlobeNewswire

11 hours ago

Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection

Indeterminate GlobeNewswire

11 hours ago

Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research

Indeterminate GlobeNewswire

11 hours ago

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Indeterminate GlobeNewswire

11 hours ago

GuideAI Health Corp. and vRad Renew Data Exclusivity Agreement to Develop AI Models for the Detection and Characterization of Multiple Vascular Diseases

Indeterminate GlobeNewswire

11 hours ago

Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden

Indeterminate GlobeNewswire

11 hours ago

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Indeterminate GlobeNewswire

11 hours ago

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire

11 hours ago

Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4

Indeterminate GlobeNewswire

11 hours ago

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Indeterminate GlobeNewswire

11 hours ago

NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes

Indeterminate GlobeNewswire

11 hours ago

ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)

Indeterminate GlobeNewswire

11 hours ago

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Indeterminate GlobeNewswire

11 hours ago

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire